Somatostatin analog treatment is associated with an increased sleep latency in patients with long-term biochemical remission of acromegaly. [electronic resource]
Producer: 20081031Description: 446-453 p. digitalISSN:- 1096-6374
- Acromegaly -- complications
- Adult
- Aged
- Aged, 80 and over
- Body Mass Index
- Case-Control Studies
- Diabetes Mellitus -- metabolism
- Female
- Human Growth Hormone -- biosynthesis
- Humans
- Male
- Middle Aged
- Remission Induction
- Sleep -- drug effects
- Sleep Wake Disorders -- etiology
- Somatostatin -- adverse effects
- Surveys and Questionnaires
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.